Unilever won't up £50 bn offer for GSK-Pfizer unit
-
Zelensky urges allies to seek 'regime change' in Russia
-
Trump envoy to inspect Gaza aid as pressure mounts on Israel
-
US theater and opera legend Robert Wilson dead at 83
-
EA shooter 'Battlefield 6' to appear in October
-
Heavyweight shooter 'Battlefield 6' to appear in October
-
Justin Timberlake says he has Lyme disease
-
Atkinson and Tongue strike as India struggle in England decider
-
US theater and opera auteur Bob Wilson dead at 83
-
Trump envoy to visit Gaza as pressure mounts on Israel
-
In Darwin's wake: Two-year global conservation voyage sparks hope
-
Microsoft valuation surges above $4 trillion as AI lifts stocks
-
Verstappen quells speculation by committing to Red Bull for 2026
-
Study reveals potato's secret tomato past
-
Trump's envoy in Israel as Gaza criticism mounts
-
Squiban solos to Tour de France stage win, Le Court maintains lead
-
Max Verstappen confirms he is staying at Red Bull next year
-
Mitchell keeps New Zealand on top against Zimbabwe
-
Vasseur signs new contract as Ferrari team principal
-
French cities impose curfews for teens to curb crime
-
Seals sing 'otherworldly' songs structured like nursery rhymes
-
India captain Gill run out in sight of Gavaskar record
-
Trump's global trade policy faces test, hours from tariff deadline
-
Study reveals potato's secret tomato heritage
-
Wirtz said I would 'enjoy' Bayern move, says Diaz
-
West Ham's Paqueta cleared of betting charges
-
AI gives stocks a lift, dollar mixed tracking Fed, tariffs
-
Authorities abandon recovery of German Olympian killed in Pakistan
-
Talks over France, Lions game 'progressing': Benazzi
-
Popovici ready to hit the beach after world swim sprint double
-
Magic Marchand adds gold to world record as McIntosh wins again
-
Sweden jihadist jailed for life over Jordan pilot burned alive
-
Zelensky signs bill ensuring anti-graft agencies' 'independence'
-
Sleepless in Singapore: Marchand wins gold, day after world record
-
England make early double strike in India series decider
-
Popovici wins 100m freestyle world gold for sprint double
-
Marchand wins 200m medley gold, day after world record
-
Thousands of Afghans scramble for chance to work in Qatar
-
Trump's envoy arrives in Israel as Gaza criticism mounts
-
McIntosh powers to third gold of worlds, 12-year-old Yu fourth
-
Hong Kong sees 3.1% growth in second quarter
-
Stocks, dollar mixed tracking Fed, tariffs, results
-
World Athletics brings in gene tests for female category eligibility
-
Trump says tariffs are making US 'great & rich' again
-
Pakistan opposition leader given 10 years for Imran Khan protests
-
India's Bumrah out of Oval finale as England bowl in fifth Test
-
Rights groups urge Nepal to reverse Telegram ban
-
BMW says can weather tariff storm despite profit plunge
-
Zelensky urges allies to push for 'regime change' in Russia
-
Renault profits slump as competition intensifies
-
Beijing officials admit 'gaps' in readiness after rains kill dozens
NYSE - LSE
| CMSC | 1.09% | 22.85 | $ | |
| RYCEF | 7.62% | 14.18 | $ | |
| RELX | 0.21% | 51.89 | $ | |
| SCS | 0% | 10.33 | $ | |
| RBGPF | 0.52% | 74.42 | $ | |
| RIO | 0.47% | 59.77 | $ | |
| BTI | 0.97% | 53.68 | $ | |
| SCU | 0% | 12.72 | $ | |
| BP | -0.31% | 32.15 | $ | |
| GSK | -4.9% | 37.15 | $ | |
| JRI | 0.15% | 13.13 | $ | |
| VOD | -2.31% | 10.81 | $ | |
| BCE | -0.86% | 23.33 | $ | |
| BCC | -1.29% | 83.81 | $ | |
| CMSD | 0.9% | 23.27 | $ | |
| NGG | 0.28% | 70.39 | $ | |
| AZN | -4.79% | 73.09 | $ |
Unilever won't up £50 bn offer for GSK-Pfizer unit
Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.
British group GSK at the weekend said it had received three unsolicited offers from Unilever for GSK Consumer Healthcare -- all of which were rejected for being too low.
US company Pfizer owns a minority stake in the unit.
"Unilever is committed to maintaining strict financial discipline to ensure that acquisitions create value for our shareholders," it said in a statement Wednesday, adding that it would not raise the offer above £50 billion ($68 billion).
British company Unilever on Monday said its "future strategic direction lies in materially expanding its presence in health, beauty and hygiene".
GSK Consumer Healthcare's leading products include Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu.
Unilever's major offerings include Magnum ice cream, Cif surface cleaner and Dove soap.
"Unilever... reiterates its commitment to continuing to improve the performance of its existing portfolio through its ongoing focus on operational excellence, its upcoming reorganisation and by rotating the portfolio to higher growth categories," it added Wednesday.
Unilever recently agreed to sell its global tea business, including brands Lipton and PG Tips, for 4.5 billion euros to private equity group CVC Capital Partners.
Ahead of Unilever appearing to have closed the door on the healthcare unit, analysts said private equity groups would likely be interested in bidding for GSK Consumer Healthcare.
Unilever's last bid in December comprised £41.7 billion in cash and £8.3 billion in Unilever shares.
The offers came as GSK was looking to spin off the consumer health division to concentrate on its main pharmaceutical arm.
GSK is led by Emma Walmsley, one of only eight women chief executives running companies on London's benchmark FTSE 100 index.
Walmsley, who headed the GSK consumer unit before its merger with Pfizer and her promotion to GlaxoSmithKline CEO, has faced severe shareholder pressure over her company's delays in producing Covid jabs and treatments.
The consumer healthcare business meanwhile had annual sales of £9.6 billion last year.
GSK owns a majority 68 percent of the unit with Pfizer the remainder.
S.F.Warren--AMWN